Glufosfamide Results From Phase 3 Clinical Trial Presented At European Cancer Conference (ECCO)

Threshold Pharmaceuticals, Inc. (Nasdaq: THLD), announced that detailed results from a Phase 3 trial of glufosfamide were presented at the European Cancer Conference (ECCO) annual meeting in Barcelona, Spain. [click link for full article]

More: continued here

Filed under: Cancer on September 28th, 2007

Comments are closed.

« Possible Safer Target For Anti Clotting Drugs Found Four Health Insurers To Resume Marketing Of Medicare Advantage Plans After Suspension »

Fioricet Supply - Buy Online: Fioricet is used to treat tension headaches.
Order Anti Depressants - Buy Online: Order Anti Depressants
RX Discount Plus - Buy Drugs: Discount plus - A method that you get extra money even if you take discount products.
RX Hint - Information and products: Find more details about Rx products only by entering.
Drug any time - : Drug any time
Privacy plus prescriptions - : Privacy plus prescriptions
The world pharmacy - : The world pharmacy
Latest News...